New embracing approach for better advanced cancer patient comprehensive care.

Autor:	Tripodoro VA; Instituto de Investigaciones Médicas Alfredo Lanari, Universidad de Buenos Aires, Argentina. E-mail: vilma.tripodoro@gmail.com.; Instituto Pallium Latinoamérica, Buenos Aires, Argentina., Llanos V; Instituto de Investigaciones Médicas Alfredo Lanari, Universidad de Buenos Aires, Argentina.; Instituto Pallium Latinoamérica, Buenos Aires, Argentina., Daud ML; Instituto Pallium Latinoamérica, Buenos Aires, Argentina., Muñoz P; Instituto Pallium Latinoamérica, Buenos Aires, Argentina., Del Mar E; Instituto de Investigaciones Médicas Alfredo Lanari, Universidad de Buenos Aires, Argentina., Tranier R; Instituto de Oncología Ángel H. Roffo, Universidad de Buenos Aires, Argentina., Sandjian S; Instituto Pallium Latinoamérica, Buenos Aires, Argentina., De Lellis S; Instituto Pallium Latinoamérica, Buenos Aires, Argentina., Días JM; Instituto Pallium Latinoamérica, Buenos Aires, Argentina., Saurí Á; Instituto de Oncología Ángel H. Roffo, Universidad de Buenos Aires, Argentina., De Simone GG; Instituto Pallium Latinoamérica, Buenos Aires, Argentina.; Hospital de Gastroenterología Carlos B. Udaondo, Buenos Aires, Argentina., Gómez-Batiste X; Cátedra de Cuidados Paliativos, Facultad de Medicina, Universidad de Vic - Universidad Central de Cataluña, Vic, Barcelona, España.
Jazyk:	angličtina
Zdroj:	Medicina [Medicina (B Aires)] 2023; Vol. 83 (2), pp. 241-255.
Abstrakt:	Introduction: Cancer patients have multiple and complex needs. Argentina has a medium-high cancer incidence. Only 14% of patients with palliative care needs have access to specialized services. This study aimed to develop and implement an integrated cancer care model in three hospitals and at home based care level. Methods: The NECPAL2 was a prospective longitudinal observational study. We report a two-year healthcare intervention and its implementation process. The NECPAL tool was used as a screening instrument. Adult cancer patients were recruited and assessed. NECPAL+ patients are those with a positive surprise question - Would you be surprised if this patient dies in the next year? (no)- and, at least one indicator of advanced disease. Patients were reassessed periodically with validated scales. Feedback was given for clinical case management. The project was developed in three consecutive stages and six phases. Data were collected for statistical analysis with a prognosis and palliative approach. Results: 2104 cancer patients screened. 681 were NECPAL+. 21% of them presented more than six parameters of severity or progression. The mean general survival was 8 months. 61.9% died within the follow-up period. Survival predictors were identified. Over 65% of patients were referred to palliative care; 10% received home-care. Areas for improvement were recognized. An implementation document was created. Discussion: This study showed that a predictive model is feasible, improving chances for timely referral and needs approach. It provided the basis for further implementation research and should encourage policymakers for embracing palliative model development for better cancer patient care.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu